Compared

Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

Condition:   AsthmaInterventions:   Drug: Fp MDPI;   Drug: FS MDPI;   Drug: PlaceboSponsor:   Teva Branded Pharmaceutical Products, R&D Inc.Not yet recruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Dedicated Asthma Program Can Improve Treatment in Kids, Teens Compared to Routine Healthcare Visits – Lung Disease News

Lung Disease News Dedicated Asthma Program Can Improve Treatment in Kids, Teens Compared to Routine Healthcare VisitsLung Disease NewsResearchers from the Children's Hospital at Montefiore (CHAM) reported that a groundbreaking primary care-based program for asthma patients, called Pediatric Preventive Asthma…

Study of Safety and Efficacy of Mometasone Furoate Used in Combination With Formoterol Fumarate Compared With Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)

Condition:   AsthmaInterventions:   Drug: MK-0887A 100/10 mcg;   Drug: MK-0887 100 mcg;   Drug: Albuterol/Salbutamol;   Drug: Prednisone/PrednisoloneSponsor:   Merck Sharp & Dohme Corp.Not yet recruiting – verified April 2016 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Patients With Asthma

Condition:   AsthmaInterventions:   Drug: QMF149;   Drug: QMF149;   Drug: MF 400;   Drug: MF 400;   Drug: salmeterol /fluticasoneSponsor:   Novartis PharmaceuticalsNot yet recruiting – verified September 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older

Condition:   AsthmaInterventions:   Drug: Treatment A: Fp MDPI;   Drug: Treatment B: FS MDPI;   Drug: Treatment C Flovent;   Drug: Treatment D:  AdvairSponsor:   Teva Branded Pharmaceutical Products, R&D Inc.Not yet recruiting – verified May 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product

Condition:   AsthmaInterventions:   Drug: Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 4 inh;   Drug: Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 1 inh;   Drug: Symbicort Turbuhaler 320/9 ug/inhalation 4 inh;   Drug: Symbicort Turbuhaler 320/9 ug/inhalation 1inh;   Drug: Placebo Symbicort Turbuhaler 320/9…

Relative Bioavailability of Tiotropium and Salmeterol After Inhalation of a Fixed Combined Dose Compared to Monocomponents in Healthy Male Volunteers

Condition:   HealthyInterventions:   Drug: Tiotropium/Salmeterol;   Drug: Serevent® Diskus®;   Drug: Spiriva®Sponsor:   Boehringer IngelheimCompleted – verified September 2014 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma

Condition:   AsthmaInterventions:   Drug: Berodual® Respimat®, low dose;   Drug: Berodual® Respimat®, high dose;   Drug: Berodual® MDISponsor:   Boehringer IngelheimCompleted – verified July 2014 View full post on ClinicalTrials.gov: asthma | received in the last 14 days